Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aerovate Therapeutics Inc (AVTE)
Aerovate Therapeutics Inc (AVTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aerovate Therapeutics Inc 930 Winter Street Suite M-500 Waltham MA 02451 USA

www.aerovatetx.com P: 617-443-2400

Description:

Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company. It focused on developing drugs for cardiopulmonary disease. The company's product pipeline consist AV-101. Aerovate Therapeutics Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 441,613
Enterprise Value, $K 419,213
Shares Outstanding, K 27,670
Annual Sales, $ 0 K
Annual Net Income, $ -51,510 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,560 K
EBIT, $ -75,200 K
EBITDA, $ -76,040 K
60-Month Beta 0.53
% of Insider Shareholders 19.30%
Float, K 22,330
% Float 80.70%
Short Volume Ratio 0.48

Growth:

1-Year Return -1.75%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.71 on 11/13/23
Next Earnings Date N/A
Earnings Per Share ttm -2.75
EPS Growth vs. Prev Qtr 6.58%
EPS Growth vs. Prev Year -26.79%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AVTE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.28%
Return-on-Assets % -50.42%
Profit Margin % 0.00%
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.52
Book Value/Share 4.55
Interest Coverage -2.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar